The latest Market Talks covering Equities. Published exclusively on Dow Jones Newswires throughout the day.

0556 GMT - China Overseas Grand Oceans Group's improving earnings outlook and solid balance sheet should support a higher valuation for the Chinese property company, say DBS Group Research analysts in a note. The company's 1H profit rose 15% on year on improved development segment earnings, they note. The company's increasing contribution from higher-margin projects should support its results recovery in the near-to-medium term, they say. Its strong operating cash flow of 6 billion yuan also places China Overseas Grand Oceans in a solid financial position. DBS raises its target price to 3.15 Hong Kong dollars from HK$2.65 and maintains a buy rating. Shares rise 5.0% to HK$2.845. (megan.cheah@wsj.com)

0545 GMT - EssilorLuxottica's mainstay Ray-Ban eyewear brand could face a long-lasting reputational hit from privacy concerns associated with its line of smartglasses, Bernstein says. Ray-Ban's smart models, produced with tech giant Meta, have suffered a public backlash from fears that wearers might use them to record interlocutors without knowledge or consent. "Women are the primary victims of smartglasses misuse [and] Meta's smartglasses have become the lightning rod in the debate around privacy, surveillance and new technologies," Bernstein's analysts write. Damper expectations for the category could in reality be positive for EssilorLuxottica, given its likely dilutive effect on margins at the Franco-Italian group, they say. Still, "we wonder how much reputational damage has been done to the Ray-Ban brand," Bernstein says. (joshua.kirby@wsj.com; @johualeokirby)

0531 GMT - Foundation Healthcare Holdings' long growth trajectory is supported by rising healthcare utilization and other tailwinds, Jefferies analysts say in a research report. This tailwind together with ambulatory care adoption and industry consolidation are quickening demand for lower-cost, coordinated care, the analysts say. The company is one of Singapore's largest private specialist platforms, and has a business model that combines specialist practices, medical centers and technology platform 'AVA' that produces benefits such as procurement efficiencies. The company's ambulatory facilities positions it to gain from migration of care out of hospitals. Jefferies initiates coverage of the stock with a buy rating and a target price of 1.10 Singapore dollars. Shares are 4.9% higher at S$0.75. (ronnie.harui@wsj.com)

0512 GMT - A recent fall in E.ON's share price opens up an attractive opportunity, Berenberg says, lifting its rating on the stock to buy from hold. Shares in the utility fell this month after investors reacted negatively to a draft return-on-equity plan published by the German energy regulator for gas distributors. "The fall in E.ON's shares creates an opening to invest in an attractive regulated utility that has the opportunity and financial firepower to sustain scaled-up growth and value-accretive investment in its German power networks," Berenberg says, lifting its target on the Frankfurt-listed stock to 21 euros. Shares closed at 17.63 euros Tuesday. (joshua.kirby@wsj.com; @joshualeokirby)

0510 GMT - China's AI-related stocks remain expensive after the correction staged in July, HSBC analysts say in a research note. The correction in the AI segment, especially hardware, suggests the AI trade was overdone, they say. This upcycle was accompanied by high valuations and positioning amid high expectations, they say. Technology, media, and telecom positions exceeded 60% of active mutual funds by 2Q, HSBC says."After the correction in July, valuations remain expensive, and further upside likely only from other AI applications and monetisation scenarios beyond AI coding," HSBC says.